Paper published in a journal (Scientific congresses and symposiums)
Effect of the addition of pioglitazone to a monotherapy or a combined oral therapy on the HbA1c level and the associated oral antidiabetics: results of the PROactive controlled prospective study
Scheen, André; Massi-Benedetti, M.; Chamonnel, B.
2007In Diabetes and Metabolism, 33 (Sp. Iss. 1), p. 122
 

Files


Full Text
Effet de l’addition de la pioglitazone à une monothérapie ou une thérapie.pdf
Author postprint (49.88 kB)
Download

All documents in ORBi are protected by a user license.

Send to



Details



Disciplines :
Endocrinology, metabolism & nutrition
Author, co-author :
Scheen, André  ;  Université de Liège - ULiège > Département des sciences cliniques > Diabétologie, nutrition et maladie métaboliques - Médecine interne générale
Massi-Benedetti, M.
Chamonnel, B.
Language :
French
Title :
Effect of the addition of pioglitazone to a monotherapy or a combined oral therapy on the HbA1c level and the associated oral antidiabetics: results of the PROactive controlled prospective study
Publication date :
March 2007
Journal title :
Diabetes and Metabolism
ISSN :
1262-3636
eISSN :
1878-1780
Publisher :
Masson Editeur, Moulineaux Cedex 9, France
Volume :
33
Issue :
Sp. Iss. 1
Pages :
S122
Available on ORBi :
since 27 February 2009

Statistics


Number of views
15 (0 by ULiège)
Number of downloads
17 (0 by ULiège)

Bibliography


Similar publications



Contact ORBi